![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Cilostazol and Probucol for Cognitive Decline after Stroke: A Cognitive Outcome Substudy of the PICASSO Trial |
Jae-Sung Lim, Sun U. Kwon, Kyung-Ho Yu, Sungwook Yu, Jong-Ho Park, Byung-Chul Lee, Mi Sun Oh, Yong-Jae Kim, Joung-Ho Rha, Yang-Ha Hwang, Ji Sung Lee, Sung Hyuk Heo, Seong Hwan Ahn, Woo-Keun Seo, Jong-Moo Park, Ju-Hun Lee, Jee-Hyun Kwon, Sung-Il Sohn, Jin-Man Jung, Hahn Young Kim, Eung-Gyu Kim, Jae-Kwan Cha, Man-Seok Park, Hyo Suk Nam, Hee-Joon Bae, Dong-Eog Kim, Jaeseol Park, Yeonwook Kang, Jimi Choi, Juneyoung Lee |
J Stroke. 2021;23(1):128-131. Published online January 31, 2021 DOI: https://doi.org/10.5853/jos.2020.03650 |
Cilostazol and Probucol for Cognitive Decline after Stroke: A Cognitive Outcome Substudy of the PICASSO Trial [P4–574]: REDUCING COGNITIVE DECLINE WITH PROBUCOL IN ISCHEMIC STROKE PATIENTS WITH HIGH RISK OF CEREBRAL HEMORRHAGE: PICASSO‐COG TRIAL Cognitive effect of cilostazol in post stroke cognitive impairment: a prospective study Effect of Probucol and Atorvastatin Combination Therapy on Cognitive Function in Patients with Acute Ischemic Stroke: A Clinical Trial Study Computer-aided Cognitive Training Combined with tDCS Can Improve Cognitive Function and Cerebrovascular Reactivity After Ischemic Stroke: A Randomized Controlled Trial Risk Prediction of Cognitive Decline after Stroke Effect of probucol on the progression of white matter hyperintensities in ischemic stroke patients with a higher burden of small vessel disease: the picasso mri-substudy The prevention of secondary stroke, cardiac outcomes and cognitive decline in patients with cerebrovascular disease: The PROGRESS trial* Cognitive recovery after stroke Cognitive outcome after bacterial meningitis |